BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 8978368)

  • 1. The pathobiology of biliary epithelia.
    Roberts SK; Ludwig J; Larusso NF
    Gastroenterology; 1997 Jan; 112(1):269-79. PubMed ID: 8978368
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dysregulation of apoptosis in the cholangiopathies and cholangiocarcinoma.
    Celli A; Que FG
    Semin Liver Dis; 1998; 18(2):177-85. PubMed ID: 9606814
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protein expression of double-stranded RNA-activated protein kinase (PKR) in intrahepatic bile ducts in normal adult livers, fetal livers, primary biliary cirrhosis, hepatolithiasis and intrahepatic cholangiocarcinoma.
    Terada T; Ueyama J; Ukita Y; Ohta T
    Liver; 2000 Dec; 20(6):450-7. PubMed ID: 11169059
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The pathology of primary biliary cirrhosis and autoimmune cholangitis.
    Ludwig J
    Baillieres Best Pract Res Clin Gastroenterol; 2000 Aug; 14(4):601-13. PubMed ID: 10976017
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New insights on the molecular and cell biology of human cholangiopathies.
    Alvaro D; Mancino MG
    Mol Aspects Med; 2008; 29(1-2):50-7. PubMed ID: 18230407
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New monoclonal antibodies reacting with bile ducts: further insights into the pathogenesis of bile ductular proliferation in biliary diseases.
    Ayres RC; Hübscher SG; Shaw J; Garner C; Joplin R; Williams A; Neuberger JM
    J Pathol; 1991 Oct; 165(2):153-61. PubMed ID: 1720818
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vanishing bile duct disorders.
    Desmet VJ
    Prog Liver Dis; 1992; 10():89-121. PubMed ID: 1296239
    [No Abstract]   [Full Text] [Related]  

  • 8. The pathobiology of biliary epithelia.
    Alpini G; McGill JM; Larusso NF
    Hepatology; 2002 May; 35(5):1256-68. PubMed ID: 11981776
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cholangiocytes in the pathogenesis of primary sclerosing cholangitis and development of cholangiocarcinoma.
    Chung BK; Karlsen TH; Folseraas T
    Biochim Biophys Acta Mol Basis Dis; 2018 Apr; 1864(4 Pt B):1390-1400. PubMed ID: 28844951
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cholangiocyte injury and ductopenic syndromes.
    Xia X; Demorrow S; Francis H; Glaser S; Alpini G; Marzioni M; Fava G; Lesage G
    Semin Liver Dis; 2007 Nov; 27(4):401-12. PubMed ID: 17979076
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of inflammation and proinflammatory cytokines in cholangiocyte pathophysiology.
    Pinto C; Giordano DM; Maroni L; Marzioni M
    Biochim Biophys Acta Mol Basis Dis; 2018 Apr; 1864(4 Pt B):1270-1278. PubMed ID: 28754451
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peptide antibiotic human beta-defensin-1 and -2 contribute to antimicrobial defense of the intrahepatic biliary tree.
    Harada K; Ohba K; Ozaki S; Isse K; Hirayama T; Wada A; Nakanuma Y
    Hepatology; 2004 Oct; 40(4):925-32. PubMed ID: 15382127
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Histopathology of chronic cholestasis and adult ductopenic syndrome.
    Desmet VJ
    Clin Liver Dis; 1998 May; 2(2):249-64, viii. PubMed ID: 15560031
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Precancerous lesions of intrahepatic cholangiocarcinoma.
    Shimonishi T; Sasaki M; Nakanuma Y
    J Hepatobiliary Pancreat Surg; 2000; 7(6):542-50. PubMed ID: 11180885
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Destruction of bile ducts in primary biliary cirrhosis.
    Nakanuma Y; Tsuneyama K; Sasaki M; Harada K
    Baillieres Best Pract Res Clin Gastroenterol; 2000 Aug; 14(4):549-70. PubMed ID: 10976014
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathobiology of biliary epithelia and cholangiocarcinoma: proceedings of the Henry M. and Lillian Stratton Basic Research Single-Topic Conference.
    Sirica AE; Nathanson MH; Gores GJ; Larusso NF
    Hepatology; 2008 Dec; 48(6):2040-6. PubMed ID: 18855901
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathology and pathogenesis of intrahepatic bile duct loss.
    Nakanuma Y; Tsuneyama K; Harada K
    J Hepatobiliary Pancreat Surg; 2001; 8(4):303-15. PubMed ID: 11521175
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A case report of cholangiectasis with cholangiocarcinoma].
    Nagata T; Ikoma H; Komiyama S; Nishio M; Murayama Y; Komatsu S; Shiozaki A; Kuriu Y; Nakanishi M; Ichikawa D; Fujiwara H; Okamoto K; Ochiai T; Sakakura C; Kokuba Y; Sonoyama T; Otsuji E
    Gan To Kagaku Ryoho; 2011 Nov; 38(12):2429-32. PubMed ID: 22202403
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A biliary HCO3- umbrella constitutes a protective mechanism against bile acid-induced injury in human cholangiocytes.
    Hohenester S; Wenniger LM; Paulusma CC; van Vliet SJ; Jefferson DM; Elferink RP; Beuers U
    Hepatology; 2012 Jan; 55(1):173-83. PubMed ID: 21932391
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Segmental cholangiectasia clinically worrisome for cholangiocarcinoma: comparison with recurrent pyogenic cholangitis.
    Zhao L; Hosseini M; Wilcox R; Liu Q; Crook T; Taxy JB; Ferrell L; Hart J
    Hum Pathol; 2015 Mar; 46(3):426-33. PubMed ID: 25600951
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.